Accredited Investors Inc. Boosts Stake in The Procter & Gamble Company (NYSE:PG)

Accredited Investors Inc. boosted its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 4.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,219 shares of the company’s stock after purchasing an additional 486 shares during the period. Accredited Investors Inc.’s holdings in Procter & Gamble were worth $2,116,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Concurrent Investment Advisors LLC increased its holdings in Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares in the last quarter. Radnor Capital Management LLC purchased a new stake in shares of Procter & Gamble in the third quarter worth $5,705,000. Welch Group LLC raised its position in shares of Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after purchasing an additional 2,990 shares during the period. GAMMA Investing LLC lifted its stake in shares of Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after buying an additional 10,777 shares in the last quarter. Finally, Quintet Private Bank Europe S.A. boosted its holdings in Procter & Gamble by 15.0% in the 3rd quarter. Quintet Private Bank Europe S.A. now owns 426,820 shares of the company’s stock worth $73,925,000 after buying an additional 55,620 shares during the period. Institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Jon R. Moeller sold 31,797 shares of Procter & Gamble stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $5,380,688.34. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares in the company, valued at $50,897,483.94. The trade was a 9.56 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the transaction, the chief executive officer now owns 13,721 shares in the company, valued at approximately $2,332,570. The trade was a 87.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 313,597 shares of company stock valued at $53,268,499 in the last three months. Company insiders own 0.18% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on PG. Stifel Nicolaus lifted their target price on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Dbs Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a report on Thursday, August 29th. Finally, TD Cowen began coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $177.00.

Get Our Latest Stock Analysis on PG

Procter & Gamble Trading Up 1.5 %

PG opened at $169.54 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock’s 50 day moving average price is $170.32 and its 200-day moving average price is $168.36. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The stock has a market cap of $399.27 billion, a price-to-earnings ratio of 29.23, a P/E/G ratio of 3.67 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the prior year, the company posted $1.83 EPS. Procter & Gamble’s quarterly revenue was down .6% on a year-over-year basis. On average, equities analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. Procter & Gamble’s payout ratio is 69.48%.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.